Waters Corp(WAT) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Oct 23 at 4:21 PM ET (Korea 10/24 05:21)
Full metrics table
| Index | S&P 500 | P/E | 113.28 | EPS (ttm) | 4 | Insider Own | 0.14% | Shs Outstand | 98.2M | Perf Week | 3.83% |
| Market Cap | 44.57B | Forward P/E | 27.49 | EPS next Y | 13.22% | Insider Trans | -2.57% | Shs Float | 98.1M | Perf Month | 5.43% |
| Enterprise Value | 49.49B | PEG | 2.28 | EPS next Q | 4 | Inst Own | 102.09% | Short Float | 3.47% | Perf Quarter | 22.22% |
| Income | 0.17B | P/S | 9.6 | EPS this Y | 11.02% | Inst Trans | 1.35% | Short Ratio | 4.21 | Perf Half Y | 46.41% |
| Sales | 4.64B | P/B | 2.93 | EPS next 5Y | 12.05% | ROA | 1.13% | Short Interest | 3.40M | Perf YTD | 19.44% |
| Book/sh | 154.7 | P/C | 82.69 | EPS past 3/5Y | -2.83% 5.19% | ROE | 1.91% | 52W High | -2.51% ($465.36) | Perf Year | 27.55% |
| Cash/sh | 5.49 | P/FCF | 118.82 | Sales past 3/5Y | 2.12% 6% | ROIC | 0.81% | 52W Low | 60.44% ($282.77) | Perf 3Y | 77.45% |
| Dividend Est. | - | EV/EBITDA | 42.56 | EPS Y/Y TTM | -63.86% | Gross Margin | 41.95% | Volatility(W/M) | 3.67% 3.19% | Perf 5Y | 24.47% |
| Dividend TTM | - | EV/Sales | 10.66 | Sales Y/Y TTM | 52.47% | Oper. Margin | 11.83% | ATR (14) | 13.86 | Perf 10Y | 190.48% |
| Dividend Ex-Date | - | Quick Ratio | 1.29 | EPS Q/Q | -156.16% | Profit Margin | 3.58% | RSI (14) | 62.85 | Recom | 1.77 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.86 | Sales Q/Q | 113.27% | SMA20 | 3.41% ($438.71) | Beta | 1.17 | Target Price | $471.43 |
| Payout | - | Debt/Eq | 0.36 | Earnings | 2026/11/3 | SMA50 | 6.96% ($424.15) | Rel Volume | 1.12 | Prev Close | $455.59 |
| Employees | 7900 | LT Debt/Eq | 0.34 | EPS/Sales Surpr. | 1.32% 1.4% | SMA200 | 23.39% ($367.67) | Avg Volume(3M) | 0.81M | Price | $453.67 |
| IPO | 1995/11/17 | Option/Short | Yes/Yes | Trades | 19750 | Volume | 907,797 | Change | -0.42% |
🧪 A global analytical science company that supplies analytical instrumentation such as liquid chromatography and mass spectrometry, along with precision chemical consumables. Founded in 1958 and headquartered in Massachusetts, USA, it is regarded as a high-quality analytical instrumentation stock holding a global leading position in the high-performance liquid chromatography field.
Over the past 1 year, on the higher side
3% below its 1-year high.
Traded about as much as usual. That is 112% of its average volume.
Next earnings report: November 3
8 days to go.
WAT has a sound balance sheet but weak earning power
After all costs, only $3.58 of every $100 in sales is left.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +11.0% this year.
Tap to view numbers
The price is about the industry average
Counting its debt, for $100 of yearly operating cash you would pay $4,256. Peers typically go for $2,566.
Tap to view numbers
Results came in about as expected
Slight tendency to beat estimates
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Buy.
Tap to view numbers
Holding long would have paid off
Bought 5 years ago, your return today would be +24.5%. The S&P 500 did +68% over the same period.
Tap to view numbers
No dividend
It reinvests profits in the business instead of paying dividends.
Ownership looks stable
Institutions hold 102.1%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
PHO Invesco Water Resources ETF 0.07% 
FIW First Trust Water ETF 0.05% 
TMFM Motley Fool Mid Cap Growth ETF 0.04% 
PIO Invesco Global Water ETF 0.04% 
EQTY Kovitz Core Equity ETF 0.04% Special products that amplify (leveraged) or invert this single stock. They decay quickly and are not for long-term holding.
PHO Invesco Water Resources ETF 2.0B FIW First Trust Water ETF 1.8B 
CGW Invesco S&P Global Water Index ETF 1.1B PIO Invesco Global Water ETF 270M 
TBLU Tortoise Global Water ETF 56M It ranks #6 of 44 in the industry
Based on market cap of $45B.
FAQ
What kind of company is WAT?
WAT belongs to the Healthcare sector and operates in the Diagnostics & Research industry.
What is the market cap of WAT?
The market cap of WAT is approximately $44.6B, ranking 353 within its sector.
What is the P/E ratio of WAT?
WAT has a P/E ratio of approximately 113.3x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for WAT?
WAT has recorded a 52-week high of $465.36 and a low of $282.77.
